Ireland
  • Europe
  • Headlines
  • Ireland
  • World
  • Business
  • Technology
  • Entertainment
  • Sports
  • Science
  • Health

Categories

  • Artificial intelligence
  • Arts and design
  • Books
  • Business
  • Celebrities
  • Computing
  • Economy
  • Entertainment
  • Entrepreneurship
  • Environment
  • Fitness
  • Gadgets
  • Genetics
  • Headlines
  • Health
  • Healthcare
  • Internet
  • Ireland
  • Jobs
  • Markets
  • Medication
  • Mental health
  • Mobile
  • Movies
  • Music
  • Nutrition
  • Personal finance
  • Physics
  • Science
  • Space
  • Sports
  • Technology
  • TV
  • Virtual reality
  • Wildlife
  • World
Ireland
  • Europe
  • Headlines
  • Ireland
  • World
  • Business
  • Technology
  • Entertainment
  • Sports
  • Science
  • Health

Browsing Tag

Copenhagen Stock Exchange:NOVO B

2 posts
HHealthcare
Novo Nordisk A/S: Ozempic® reduces the risk of heart attack, stroke and death by 23% compared to dulaglutide in the first head-to-head real-world study
Read More

Novo Nordisk’s sales increased by 12% in Danish kroner and

  • November 5, 2025
Bagsværd, 5 November, 2025 – Financial report for the period 1 January 2025 to 30 September 2025   …
HHealthcare
Novo Nordisk A/S: Ozempic® reduces the risk of heart attack, stroke and death by 23% compared to dulaglutide in the first head-to-head real-world study
Read More

Novo Nordisk and Omeros announce asset purchase and license

  • October 15, 2025
Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk’s Rare Disease…
Ireland
www.europesays.com